MedPath

Investigating the effect of a supplement of hydroalcoholic extract of Eryngium on the metabolic marker in type 2 diabetic patients

Phase 3
Recruiting
Conditions
Type 2 diabetes.
Diabetes mellitus due to underlying condition
Registration Number
IRCT20181006041252N7
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
84
Inclusion Criteria

Type 2 diabetes for at least 2 years
HbA1C less than 8.5
Patients aged 20-60 years
Non-insulin treated diabetic patients

Exclusion Criteria

Pregnancy and breastfeeding
Renal and cardiovascular disorders and chronic underlying disease
Insulin therapy
Micro and macro-vascular diabetic complications
Use of other herbal medicines that have an effect on diabetes
Smoking or alcohol abuse within a month before the study.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath